ECP 2019 Final Programme

71 Monday, 9 Sept ECP 2019 · Nice Two-Day Molecular Pathology Diagnostics Symposium 005 15:57–16:21 UK NEQAS: NGS, variant nomenclature and reporting Jennifer Fairley, United Kingdom 006 16:21–16:45 French quality assurance programme Gen&tiss Karen Leroy, France MD-04 2-Day MD Symposium 17:15–19:15 Clio NGS – beyond mutation testing Chairs: Marjolijn Ligtenberg, The Netherlands Sabine Merkelbach-Bruse, Germany 001 17:15–17:45 AMP guidelines for variant reporting Marilyn Li, USA Planned jointly with AMP 002 17:45–18:15 CNV detection from NGS data Astrid Eijkelenboom, The Netherlands 003 18:15–18:45 Fusion gene detection using RNAseq Bastiaan Tops, The Netherlands 004 18:45–19:15 Moving beyond DNA sequence: genome-wide profiling of plasma DNA Samantha Perakis, Austria e Tuesday, 10 September 2019 MD-05 2-Day MD Symposium 08:30–09:30 Clio Selected Abstracts Chairs: Sabine Merkelbach-Bruse, Germany Etienne Rouleau, France 001 08:30–08:42 Differentially expressed immune related genes in metastatic vs. non-metastatic LUMA, LUMB1 and TNBC primary breast carcinoma cases Anna Maria Tokes, Hungary O. Rusz, C. Pollner-Szundi, L. Madaras, A. Kovács, B. Molnár, I. Vári-Kakas, J. Kulka 002 08:42–08:54 Tumour mutational burden analysis: implementation in routine diagnostics Leonie Kroeze, The Netherlands E. Kamping, D. von Rhein, E. Jansen, R. de Voer, M. Barberis, J. Botling, E. Garrido-Martin, F. Haller, L. Lacroix, B. Maes, S. Merkelbach-Bruse, V. Pestinger, N. Pfarr, A. Stenzinger, K. Grünberg, M. Ligtenberg 003 08:54–09:06 Role of HR23b in response to HDAC inhibitors and their effect on immunothera- py targets Svenja Wagener-Ryczek, Germany C. Alidousty, C. Heydt, J. Fassunke, S. Merkelbach-Bruse, R. Buettner, M. A. Ihle 004 09:06–09:18 MET exon 14 skipping mutations in non small cell lung cancer: efficient routine diagnostics, histopathology and clinical response upon targeted treatment Willemina Geurts-Giele, The Netherlands M. Pruis, J. von der Thüsen, I. Meijssen, W. Dinjens, J. Aerts, M. Lolkema, M. Paats, H. J. Dubbink 005 09:18–09:30 The diagnostic landscape and yield of predictive somatic molecular analyses for stratification of cancer therapy in The Netherlands Elisabeth Steeghs, The Netherlands E. K. de Jong, R. W. Willems, Q. J. Voorham, P. A. Seegers, K. Grünberg, M. Ligtenberg Tuesday, 10 Sept

RkJQdWJsaXNoZXIy Mzg2Mjgy